Skip to main content
. 2018 Feb 8;9(17):13682–13693. doi: 10.18632/oncotarget.24455

Figure 6. Positive correlation between TP53 mutation and PD-L1 Expression (SP142).

Figure 6

Patients with TP53 mutation had significantly higher PD-L1 TPS (Wilcoxon rank-sum test). (A) The height of the histogram represents the number of patients. The two panels compare TP53 WT on the left with mutant TP53 on the right. Within each panel, the first data point represents the number of patients expressing PD-L1 less than 50% and the second data point represents the number of patients expressing PD-L1 more than or at 50%. (B) TP53 versus PD-L1 expression as a continuous variable in box plot form.